More News – Page 24
-
NewsResearcher helps develop new technique to explore oceanic microbes
A new method makes it possible to collect microbial natural products where they are produced in the wild, without the need for lab culture. It uses an absorbent resin called HP-20, which acts like a sponge to capture the chemicals released by microbes.
-
NewsNew guideline for Helicobacter pylori includes change to primary treatment recommendation
New guidelines on the treatment of Helicobacter pylori (H. pylori) infection warn against prescribing PPI triple therapy, instead advising practitioners to use bismuth quadruple therapy or one of the other suggested treatment options.
-
NewsFungus uses surface protein of its spores to weaken human immune system
An international research team discovered a special enzyme on the surface of the spores of Aspergillus fumigatus apparently suppresses the release of pro-inflammatory substances by immune cells, making it easier for the pathogen to spread in the tissue.
-
NewsPublic health experts put out call for collaboration in antiviral therapeutics development coalition
Establishing a global therapeutics development coalition is a vital next step to invigorate the therapeutics pipeline and drive advocacy for increased investment and coordination of end-to-end therapeutics development, say a group of public health experts.
-
NewsStudy uncovers the specialized immune cells that fight COVID-19
A team of researchers from Osaka University has pinpointed the B cells responsible for boosting COVID-19 immunity after vaccination.
-
NewsResearchers discover key gene regulating virulence of fungus that causes severe lung infections
Scientists have found a potential target for novel therapeutic strategies to combat fungal infections caused by Aspergillus fumigatus and are now looking for a molecule that inactivates the protein expressed by the gene as a basis for a drug.
-
NewsImmune cells prevent lung healing after viral infection
Investigators have discovered a pathway by which immune cells prevent the lungs’ protective barrier from healing after viral infections like COVID-19.
-
NewsNew study provides insight to why Covid vaccines hit some harder than others
Scientists have highlighted factors that may explain why some people perceived more side effects from the SARS-CoV2 vaccine than others, including stress, exercise, and use of hormonal birth control.
-
NewsFirst narrow-spectrum antibiotic successfully eliminates Fusobacterium nucleatum in breakthrough study
Scientists found that FP 100 (Hygromycin A), a first-in-class, small molecule, narrow-spectrum antibiotic, successfully eradicates Fusobacterium nucleatum without harming the oral or gut microbiomes.
-
NewsInfections following hip replacement associated with an increased risk of death, study finds
Patients who develop a periprosthetic joint infection (PJI) after a total hip replacement have more than a five-fold increased risk of mortality within 10 years, according to new research.
-
NewsObesity may increase susceptibility to contracting COVID-19
Electronic health record data revealed that individuals with obesity were 34% more likely to become COVID positive after reported exposure than individuals without obesity.
-
NewsFirst phase of polio campaign concludes successfully in Gaza
More than 187,000 children under ten years of age were vaccinated with novel oral polio vaccine type 2 (nOPV2) in central Gaza during the first phase of a two-round polio vaccination campaign, conducted between 1–3 September 2024.
-
NewsMeet the Global Ambassadors: Our Q&A with Sergio L Alves jr
The Microbiologist chats with our new Global Ambassador for Brazil, Sergio L Alves jr, Associate Professor at the Federal University of Fronteira Sul (UFFS).
-
NewsInvestigational mpox mRNA vaccine reduces disease severity in primates compared to available vaccines
A new mpox vaccine candidate more effectively limits symptoms and disease duration in primates that were infected with a lethal strain of the mpox virus when compared to a currently licensed modified vaccinia Ankara (MVA) vaccine.
-
NewsH5 influenza vaccines: what needs to be done to reduce the risk of a pandemic
As the global threat of H5N1 influenza looms, three international vaccine and public health experts say it is time to fully resource and support a robust strategy to address this and future potential pandemic influenza threats.
-
NewsWHO data show shock increase in annual cholera deaths
The World Health Organization (WHO) has published global cholera statistics for 2023, showing an increase in cases and deaths.
-
NewsNewly discovered viruses in parasitic nematodes could change our understanding of how they cause disease
New research shows that parasitic nematodes, responsible for infecting more than a billion people globally, carry viruses that may solve the puzzle of why some cause serious diseases.
-
NewsWild and human-cared spotted dolphins harbor different gastrointestinal microbiomes
A recent study highlighted the significant role of food source variations in shaping the gut microbiome of spotted dolphins, even when they inhabit similar environments.
-
NewsTechnique boosts biofilm growth for efficient wastewater treatment
A biological method to treat sewage using moving, biofilm-covered plastic items known as carriers has been gaining prominence, and researchers have found ways to make the process more efficient.
-
NewsSevere COVID-19 can involve either exacerbated lung inflammation or high viral replication
Researchers report a study based on autopsies of 47 patients who died after being infected by the ancestral strain of SARS-CoV-2. The findings will support clinical decisions on the treatment of critical cases.
